Exploration of the Health Benefits of Probiotics Under High-Sugar and High-Fat Diets
DOI:
https://doi.org/10.62836/amr.v2i1.002Keywords:
high-sugar and high-fat diet, probiotics, gut health, metabolic pathology, chronic disease preventionAbstract
In recent years, high-sugar and high-fat diets (HSHF) have become a major global health issue, closely associated with the onset of various chronic diseases. Probiotics, as microorganisms that regulate gut microbiota balance, have gained significant attention for their potential role in modulating the metabolic disturbances induced by HSHF diets. This paper describes the potential mechanisms through which probiotics counteract the negative effects of HSHF diets and their associated health benefits. By analyzing recent research literature, we explore the role of probiotics in regulating gut barrier function, reducing inflammatory responses, modulating the immune system, and improving lipid metabolism. Additionally, the use of probiotics has been linked to an increase in gut microbiota diversity and a reduction in inflammatory markers under pathological conditions. Although existing studies provide support for the health benefits of probiotics, further clinical trials and in-depth research are required to better understand their specific effects and mechanisms in clinical applications. This paper highlights the need for future research to focus on the specificity of probiotic effects under particular health conditions, dose-response relationships, and the mechanisms of host-probiotic interactions. Through these studies, we aim to gain a deeper understanding of the potential of probiotics in the prevention and treatment of HSHF diet-related diseases, thereby providing more effective strategies for public health.
References
Zhao LJ. Relationship between Thyroid Hormones, SUA, Hcy Levels, and Carotid Intima-Media Thickness in Patients with Normal Thyroid Function and T2DM. Aerospace Medicine Journal 2023; 35(12): 1415–1418.
Pan J, Zhang CC. Effects of Liraglutide Combined with Metformin on Type 2 Diabetes Patients with Coronary Heart Disease and Its Impact on Cardiac Function Indicators. Modern Medicine and Health Research Electronic Journal 2023; 8(24): 67–69.
Long Z, Zhang X, Sun Q, et al. Evolution of Metabolic Disorders in Rats Fed High Sucrose or High Fat Diets: Focus on Redox State and Mitochondrial Function. General and Comparative Endocrinology 2017; 242: 92–100.
Li YF. The Effect and Mechanism of High-Sugar and High-Fat Diet on Traumatic Brain Injury in Rats. Master’s Thesis, Anhui Medical University, Anhui, China, 2023. https://doi.org/10.26921/d.cnki.ganyu.2024.001331.
Guan JF, An LL, Han JQ, et al. Liraglutide Regulates Microglial/Macrophage Polarization through NOX2 to Improve Cerebral Ischemic Injury in Diabetic Rats. Journal of the Army Medical University 2022; 44(11): 1136–1142. https://doi.org/10.16016/j.2097-0927.202111090.
Liu TC, Kern JT, Jain U, et al. Western Diet Induces Paneth Cell Defects through Microbiome Alterations and Farnesoid X Receptor and Type I Interferon Activation. Cell Host & Microbe 2021; 29(6): 988–1001.e6.
Bäckhed F, Ley RE, Sonnenburg JL, et al. Host-Bacterial Mutualism in the Human Intestine. Science 2005; 307(5717): 1915–1920.
Niu MM, Zhao YQ, Xiang L, et al. Effects of High-Fat and High-Sugar Diet on the Gut Microbiota of Bama Miniature Pigs. Experimental Animal Science 2023; 40(03): 7–11.
Clyde D. Gut Microbial Structural Variation Links to Human Health. Nature Reviews Genetics 2019; 20: 318–319.
Smits MM, Fluitman KS, Herrema H, et al. Liraglutide and Sitagliptin Have No Effect on Intestinal Microbiota Composition: A 12-Week Randomized Placebo-Controlled Trial in Adults with Type 2 Diabetes. Diabetes Metabolism 2021; 47(5): 101223. https://doi.org/10.1016/j.diabet.2021.101223.
Liu J, Xia YJ, Xiong ZQ, et al. Research Progress on the Alleviating Effect of Probiotics on Type 2 Diabetes. Food Industry Science and Technology 2022; 43(1): 466–471.
Bilqeesa B, Kumar BB. Multifarious Cholesterol-Lowering Potential of Lactic Acid Bacteria Equipped with Desired Probiotic Functional Attributes. 3 Biotech 2020; 10(5): 200.
Sisi L, Subhajit M, Juanjuan L, et al. Mucosal Immunity-Mediated Modulation of the Gut Microbiome by Oral Delivery of Probiotics into Peyer’s Patches. Science Advances 2021; 7(20): eabf0677.
Giorgio FL, Peter W, Hasan MM. Probiotics and the Gut Immune System: Indirect Regulation. Probiotics and Antimicrobial Proteins 2018; 10(1): 11–21.
Tsai YT, Cheng PC, Pan TM. The Immunomodulatory Effects of Lactic Acid Bacteria for Improving Immune Functions and Benefits. Applied Microbiology and Biotechnology 2013; 96(4): 853–862.
Jia X, Xu W, Zhang L, et al. Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia. Frontiers in Cellular and Infection Microbiology 2021; 11: 634780–634780.
Kumar M, Rakesh S, Nagpal R, et al. Probiotic Lactobacillus Rhamnosus GG and Aloe Vera Gel Improve Lipid Profiles in Hypercholesterolemic Rats. Nutrition 2013; 29(3): 574–579.
Liu Y, Wang J. AI-Driven Health Advice: Evaluating the Potential of Large Language Models as Health Assistants. Journal of Computational Methods in Engineering Applications 2023; 3: 1–7. https://doi.org/10.62836/jcmea.v3i1.030106.
Lye H, Rusul G, Liong M. Removal of Cholesterol by Lactobacilli via Incorporation and Conversion to Coprostanol. Journal of Dairy Science 2010; 93(4): 1383–1392.
Jiang RS, Zhang L, Guan QF, et al. Research Progress on the Role of Short-Chain Fatty Acids in Type 2 Diabetes. Chinese General Practice 2023; 27(24): 3031–3037.
Zhang LT, Li JY, Kong SW, et al. Effects and Mechanisms of Probiotic Lactobacillus Plantarum Lipopolysaccharide in Alleviating Mouse Colitis. Journal of Food Science and Technology 2023; 1–12. https://doi.org/10.1151.TS.20241216.1558.002.
Jacques A, Chantal C, Aurélie W, et al. Intestinal Mucosal Adherence and Translocation of Commensal Bacteria at the Early Onset of Type 2 Diabetes: Molecular Mechanisms and Probiotic Treatment. EMBO Molecular Medicine 2011; 3(9): 559–572.
Bäckhed F, Manchester JK, Semenkovich CF, et al. Mechanisms Underlying the Resistance to Diet-Induced Obesity in Germ-Free Mice. Proceedings of the National Academy of Sciences USA 2007; 104(3): 979–984.
Yang YH, Li L, Huang HL, et al. The Relationship between Gut Microbiota and Diseases. Pharmaceutical Research 2015; 6(34): 353–356.
Cani PD, Possemiers S, Van de Wiele T, et al. Changes in Gut Microbiota Control Inflammation in Obese Mice through a Mechanism Involving GLP-2-Driven Improvement of Gut Permeability. Gut 2009; 58(8): 1091–1103.
Stephanie H, Katharina V, Christoph C, et al. Differential Targeting of the E-Cadherin/β-Catenin Complex by Gram-Positive Probiotic Lactobacilli Improves Epithelial Barrier Function. Applied and Environmental Microbiology 2012; 78(4): 1140–1147.
Julio P, Javier FR, Mercedes G, et al. Mechanisms of Action of Probiotics. Advances in Nutrition 2019; 10: S49–S66.
Markowiak-Kopeć P, Śliżewska K. The Effect of Probiotics on the Production of Short-Chain Fatty Acids by the Human Intestinal Microbiome. Nutrients 2020; 12(4): 1107.
Zhang YJ. Research Progress on the Role of Fermented Dairy Products in Improving Gastrointestinal Function. Modern Food Science and Technology 2023; 39(07): 352–357. https://doi.org/10.13982/j.mfst.1673-9078.2023.7.0640.
Ehses JA, Perren A, Eppler E, et al. Increased Number of Islet-Associated Macrophages in Type 2 Diabetes. Diabetes 2007; 56: 2763–2770.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Pei-Min Lu
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommerical-NoDerivatives 4.0 International License.
